Literature DB >> 3009683

Sphingomyelinases and Niemann-Pick disease.

T Levade, R Salvayre, L Douste-Blazy.   

Abstract

In the first part the properties of normal mammalian sphingomyelinases are reviewed: The lysosomal acid sphingomyelinase is a polymeric glycoprotein (subunit Mr between 28 000 and 70 000) which hydrolyses natural sphingomyelin, coloured and fluorescent semi-synthetic analogues (trinitrophenyl-aminolauryl-sphingomyelin and pyrenedecanoyl-sphingomyelin) and the synthetic analogue 2-N-hexadecanoylamido-nitrophenyl-phosphorylcholine. The suitability of these substrates and of synthetic fluorescent derivatives of methylumbelliferone is discussed. The effect of lipids, detergents and other effectors on the enzyme activity is also described. The neutral sphingomyelinase from brain tissue, localized in cell membranes, has a high Mr (160 000 and 600 000), is heat labile, hydrolyses sphingomyelin and its coloured and fluorescent analogues, but not 2-N-hexadecanoylamido-nitrophenyl-phosphorylcholine. A new method is available for determining enzyme activity in the intact cell through the utilization of endogenous or exogenous sphingomyelin as substrate. In the second part of the review, the classification of Niemann-Pick disease, the characteristic features of each type and the biological tools used for the diagnosis are reported. Experimental models (animal models and cellular models in culture) are reviewed with a particular attention to a new model system, Epstein-Barr virus-transformed lymphoid cell lines.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3009683

Source DB:  PubMed          Journal:  J Clin Chem Clin Biochem        ISSN: 0340-076X


  14 in total

1.  Involvement of FAN in TNF-induced apoptosis.

Authors:  B Ségui; O Cuvillier; S Adam-Klages; V Garcia; S Malagarie-Cazenave; S Lévêque; S Caspar-Bauguil; J Coudert; R Salvayre; M Krönke; T Levade
Journal:  J Clin Invest       Date:  2001-07       Impact factor: 14.808

2.  Acid sphingomyelinase deficiency increases susceptibility to fatal alphavirus encephalomyelitis.

Authors:  Ching G Ng; Diane E Griffin
Journal:  J Virol       Date:  2006-08-30       Impact factor: 5.103

3.  A neutral sphingomyelinase resides in sphingolipid-enriched microdomains and is inhibited by the caveolin-scaffolding domain: potential implications in tumour necrosis factor signalling.

Authors:  R J Veldman; N Maestre; O M Aduib; J A Medin; R Salvayre; T Levade
Journal:  Biochem J       Date:  2001-05-01       Impact factor: 3.857

4.  Uptake and degradation of several pyrenesphingomyelins by skin fibroblasts from control subjects and patients with Niemann-Pick disease. Effect of the structure of the fluorescent fatty acyl residue.

Authors:  T Levade; S Gatt; R Salvayre
Journal:  Biochem J       Date:  1991-04-01       Impact factor: 3.857

5.  Roles for tumor necrosis factor receptor p55 and sphingomyelinase in repairing the cutaneous permeability barrier.

Authors:  J M Jensen; S Schütze; M Förl; M Krönke; E Proksch
Journal:  J Clin Invest       Date:  1999-12       Impact factor: 14.808

6.  A model of the acid sphingomyelinase phosphoesterase domain based on its remote structural homolog purple acid phosphatase.

Authors:  Marian Seto; Marc Whitlow; Margaret A McCarrick; Subha Srinivasan; Ying Zhu; Rene Pagila; Robert Mintzer; David Light; Anthony Johns; Janet A Meurer-Ogden
Journal:  Protein Sci       Date:  2004-12       Impact factor: 6.725

7.  Niemann-Pick type B disease. Identification of a single codon deletion in the acid sphingomyelinase gene and genotype/phenotype correlations in type A and B patients.

Authors:  O Levran; R J Desnick; E H Schuchman
Journal:  J Clin Invest       Date:  1991-09       Impact factor: 14.808

8.  Evidence for both endogenous and exogenous sources of the sphingomyelin storage in lymphoid cell lines from patients with Niemann-Pick disease types A and B.

Authors:  T Levade; R Salvayre; A Maret; L Douste-Blazy
Journal:  J Inherit Metab Dis       Date:  1988       Impact factor: 4.982

9.  Effect of host cell lipid metabolism on alphavirus replication, virion morphogenesis, and infectivity.

Authors:  Ching G Ng; Isabelle Coppens; Dhanasekaran Govindarajan; John Pisciotta; Vladimir Shulaev; Diane E Griffin
Journal:  Proc Natl Acad Sci U S A       Date:  2008-10-09       Impact factor: 11.205

10.  Evidence against involvement of the acid lysosomal sphingomyelinase in the tumor-necrosis-factor- and interleukin-1-induced sphingomyelin cycle and cell proliferation in human fibroblasts.

Authors:  N Andrieu; R Salvayre; T Levade
Journal:  Biochem J       Date:  1994-10-15       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.